Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
暂无分享，去创建一个
F. Muntoni | L. Servais | T. Maisonobe | T. Stojkovic | P. Machado | L. Féasson | C. Hourde | M. Hanna | T. Voit | A. Buj-Bello | V. Mariot | J. Dumonceaux | R. Joubert | R. Le Panse | C. Bogni | O. Benvensite